Navigating PARP Inhibitor Resistance in Ovarian Cancer: Bridging Mechanistic Insights To Clinical Translation

Current Treatment Options in Oncology · Published 2025-08-19 · DOI 10.1007/s11864-025-01347-z

Authors being retrieved — see the publisher record. https://doi.org/10.1007/s11864-025-01347-z

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2025

Related articles

Revolutionizing Breast Cancer Therapeutics: Intersecting Frontiers of Precision Medicine, Nanotechnology, and Drug Delivery Innovations · Current Treatment Options in Oncology · 2025 · Same journal
Cardiotoxicity of Targeted Therapies in Hematologic Malignancies: From Molecular Mechanisms to Clinical Management · Current Treatment Options in Oncology · 2026 · Same journal
Second-Line Treatment in cholangiocarcinoma - Current State of the Art and Future Perspectives · Current Treatment Options in Oncology · 2025 · Same journal
Updates on Therapy Options in Fit and Unfit Patients with Newly Diagnosed AML · Current Treatment Options in Oncology · 2025 · Same journal
Transforming a Roadblock into a Roadmap: Evolving HFSR Management From Adverse Event to Efficacy Biomarker · Current Treatment Options in Oncology · 2026 · Same journal
The Use of Targeted Therapy in Pediatric Acute Lymphoblastic Leukemia: Exploring Novel Approaches and Emerging Therapies · Current Treatment Options in Oncology · 2026 · Same journal
Advanced Mucosal Melanoma Therapies: Current Status and Future Directions · Current Treatment Options in Oncology · 2026 · Same journal
Local Recurrence After Pancreatic Cancer Resection: A Multidisciplinary Review of Risk Factors and Potential Causes, Diagnostic Innovations, Emerging Therapeutic Frontiers, and Prevention Strategies · Current Treatment Options in Oncology · 2026 · Same journal
Research Priorities and Future Directions in Cardio-Oncology · Current Treatment Options in Oncology · 2026 · Same journal
Role of Troponins in CardioOncology · Current Treatment Options in Oncology · 2026 · Same journal